Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation
Browning S, Quillen K, Sloan JM, Doros G, Sarosiek S, Sanchorawala V. Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation. Blood 2017, 130: 1383-1386. PMID: 28698204, DOI: 10.1182/blood-2017-06-788729.Peer-Reviewed Original ResearchAdultAgedAged, 80 and overCohort StudiesCombined Modality TherapyDisease-Free SurvivalDose-Response Relationship, DrugFemaleHematopoietic Stem Cell TransplantationHumansImmunoglobulin Light ChainsImmunoglobulin Light-chain AmyloidosisKaplan-Meier EstimateMaleMelphalanMiddle AgedMolecular Targeted TherapyParaproteinsRecurrenceRetrospective StudiesSalvage Therapy